IOM Considers Companion Dx | GenomeWeb

A clearer and more certain regulatory environment will be required for US businesses working on co-developed companion diagnostic tests to be able to tap the potential such tests offer for personalized medicine, according to a new editorial in the Online First publication of the Journal of the American Medical Association.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Lessons Learned

Tread Carefully

This Week in Cell

Retired Chimps

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."